Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ HB Fuller Co (FUL) Stock Forecast & Price Prediction United States | NYSE | Basic Materials | Specialty Chemicals
$61.25
+0.58 (0.96%)Did FUL Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if HB Fuller is one of their latest high-conviction picks.
Based on our analysis of 11 Wall Street analysts, FUL has a bullish consensus with a median price target of $70.00 (ranging from $58.00 to $84.00). The overall analyst rating is Strong Buy (8.6/10). Currently trading at $61.25, the median forecast implies a 14.3% upside. This outlook is supported by 5 Buy, 1 Hold, and 1 Sell ratings.
Conversely, the most conservative target is provided by David Begleiter at Deutsche Bank, suggesting a 5.3% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for FUL.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 30, 2026 | Citigroup | Patrick Cunningham | Buy | Maintains | $70.00 |
| Mar 27, 2026 | UBS | Lucas Beaumont | Neutral | Maintains | $63.00 |
| Mar 19, 2026 | Citigroup | Patrick Cunningham | Buy | Maintains | $67.00 |
| Jan 16, 2026 | Citigroup | Patrick Cunningham | Buy | Maintains | $76.00 |
| Jan 16, 2026 | UBS | Lucas Beaumont | Neutral | Maintains | $66.00 |
| Nov 21, 2025 | UBS | Lucas Beaumont | Neutral | Initiates | $60.00 |
| Oct 22, 2025 | Citigroup | Patrick Cunningham | Buy | Upgrade | $70.00 |
| Sep 26, 2025 | Seaport Global | Michael Harrison | Buy | Upgrade | $80.00 |
| Sep 26, 2025 | Citigroup | Patrick Cunningham | Neutral | Maintains | $62.00 |
| Jun 27, 2025 | Baird | Ghansham Panjabi | Outperform | Maintains | $75.00 |
| Jun 27, 2025 | JP Morgan | Jeffrey Zekauskas | Underweight | Maintains | $54.00 |
| Apr 17, 2025 | Baird | Ghansham Panjabi | Outperform | Upgrade | $60.00 |
| Mar 28, 2025 | JP Morgan | Jeffrey Zekauskas | Underweight | Maintains | $50.00 |
| Mar 5, 2025 | Seaport Global | Michael Harrison | Neutral | Downgrade | $N/A |
| Jan 22, 2025 | Deutsche Bank | David Begleiter | Buy | Maintains | $72.00 |
| Jan 17, 2025 | JP Morgan | Jeffrey Zekauskas | Underweight | Maintains | $60.00 |
| Jan 3, 2025 | Citigroup | Patrick Cunningham | Neutral | Maintains | $68.00 |
| Dec 18, 2024 | Citigroup | Patrick Cunningham | Neutral | Maintains | $78.00 |
| Dec 3, 2024 | Citigroup | Neutral | Maintains | $N/A | |
| Apr 1, 2024 | Baird | Ghansham Panjabi | Neutral | Maintains | $90.00 |
The following stocks are similar to HB Fuller based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
HB Fuller Co has a market capitalization of $3.34B with a P/E ratio of 21.1x. The company generates $3.46B in trailing twelve-month revenue with a 4.6% profit margin.
Revenue growth is -2.3% quarter-over-quarter, while maintaining an operating margin of +8.4% and return on equity of +8.3%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Global supplier of adhesives and specialty chemicals.
H.B. Fuller Co. generates revenue by supplying adhesives, sealants, and specialty chemical products to various industrial sectors, including packaging and construction. The company focuses on developing innovative solutions that improve product performance and sustainability, allowing it to maintain strong customer relationships and capture diverse market opportunities.
Founded in 1887 and based in St. Paul, Minnesota, H.B. Fuller is a key player in industries such as aerospace, hygiene, and electronics. Its commitment to sustainability and innovation positions the company as a vital contributor to essential industrial processes and emerging technologies.
Basic Materials
Specialty Chemicals
7,500
Ms. Celeste Beeks Mastin
United States
1990
FUL vs. HWKN: Which Stock Is the Better Value Option?
H.B. Fuller (NYSE: FUL) has opened a new Aerospace Manufacturing Center of Excellence to enhance growth in aviation, space, and defense markets, aligning with its long-term growth strategy.
H.B. Fullerโs new Aerospace Manufacturing Center signals expanded capabilities in high-growth markets, potentially boosting revenue and market share, which could positively impact stock performance.
H. B. Fuller (FUL) and Hawkins (HWKN) are notable companies in the Chemical - Specialty sector, attracting interest from investors.
H. B. Fuller and Hawkins are key players in the Chemical - Specialty sector, indicating potential investment opportunities and market trends within this niche.
Year-to-date, 36 of 58 Dividend Kings have outperformed the SPY, averaging a 7.03% gain compared to SPY's 4.18%. Twenty-seven are deemed undervalued, with expected long-term returns of at least 10%.
Dividend Kings' strong performance and undervaluation suggest potential for higher returns, indicating a favorable investment opportunity compared to the broader market.
H.B. Fuller Company (NYSE: FUL) raised its quarterly cash dividend from $0.2350 to $0.2450 per share, payable on May 14, 2026, to shareholders of record on April 30, 2026.
H.B. Fullerโs dividend increase signals financial stability and commitment to returning value to shareholders, potentially attracting income-focused investors and boosting stock demand.
H. B. Fuller (FUL) and Novozymes A/S (NVZMY) are notable companies in the Chemical - Specialty sector that may interest investors.
The mention of H. B. Fuller and Novozymes A/S highlights key players in the specialty chemicals sector, signaling potential investment opportunities and market trends for investors.
Investors in the Chemical - Specialty sector may consider H. B. Fuller (FUL) and Novozymes A/S (NVZMY) as potential stock options.
H. B. Fuller and Novozymes A/S are highlighted as potential investments in the Chemical - Specialty sector, indicating growth opportunities and sector interest.
Based on our analysis of 11 Wall Street analysts, HB Fuller Co (FUL) has a median price target of $70.00. The highest price target is $84.00 and the lowest is $58.00.
According to current analyst ratings, FUL has 5 Buy ratings, 1 Hold ratings, and 1 Sell ratings. The stock is currently trading at $61.25. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict FUL stock could reach $70.00 in the next 12 months. This represents a 14.3% increase from the current price of $61.25. Please note that this is a projection by Wall Street analysts and not a guarantee.
H.B. Fuller Co. generates revenue by supplying adhesives, sealants, and specialty chemical products to various industrial sectors, including packaging and construction. The company focuses on developing innovative solutions that improve product performance and sustainability, allowing it to maintain strong customer relationships and capture diverse market opportunities.
The highest price target for FUL is $84.00 from at , which represents a 37.1% increase from the current price of $61.25.
The lowest price target for FUL is $58.00 from David Begleiter at Deutsche Bank, which represents a -5.3% decrease from the current price of $61.25.
The overall analyst consensus for FUL is bullish. Out of 11 Wall Street analysts, 5 rate it as Buy, 1 as Hold, and 1 as Sell, with a median price target of $70.00.
Stock price projections, including those for HB Fuller Co, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.